Dissecting physiological roles of estrogen receptor α and β with potent selective ligands from structure-based design

Molecular Endocrinology

Volumn 18, Issue 7, 2004, Pages 1599-1609

  Hillisch, Alexander ^a,b   Peters, Olaf ^b   Kosemund, Dirk ^b   Müller, Gerd ^b   Walter, Alexander ^b   Schneider, Birgitt ^a   Reddersen, Gudrun ^a   Elger, Walter ^a   Fritzemeier, Karl Heinrich ^b  

^a EnTec Gesell F E   (Germany)

^b BAYER PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; LUTEINIZING HORMONE; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG EFFECT; HUMAN; HUMAN CELL; HYPOPHYSIS; LIGAND BINDING; LIVER; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SIGNAL TRANSDUCTION; UTERUS;

AMINO ACID SEQUENCE; ANGIOTENSIN I; ANIMALS; BINDING SITES; BIOCHEMISTRY; BONE AND BONES; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; FOLLICLE STIMULATING HORMONE; LIGANDS; LIVER; LUTEINIZING HORMONE; MALE; MOLECULAR SEQUENCE DATA; PITUITARY GLAND; RATS; RATS, WISTAR; STRUCTURE-ACTIVITY RELATIONSHIP; UTERUS;

ANIMALIA;

EID: 3042840787     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2004-0050     Document Type: Article

References (42)

1. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA 1996 Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93:5925-5930
2. Dechering K, Boersma C, Mosselman S 2000 Estrogen receptors α and β: two receptors of a kind? Curr Med Chem 7:561-576
3. Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M, Gustafsson JA 2001 Mechanisms of estrogen action. Physiol Rev 81:1535-1565
4. Pettersson K, Gustafsson JA 2001 Role of estrogen receptor β in estrogen action. Annu Rev Physiol 63: 165-192
5. Kuiper GG, Gustafsson JA 1997 The novel estrogen receptor-β subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens. FEBS Lett 410:87-90
6. Frasor J, Barnett DH, Danes JM, Hess R, Parlow AF, Katzenellenbogen BS 2003 Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) α activity by ERβ in the uterus. Endocrinology 144:3159-3166
7. Warner M, Nilsson S, Gustafsson JA 1999 The estrogen receptor family. Curr Opin Obstet Gynecol 11:249-254
8. Korach KS, Couse JF, Curtis SW, Washburn TF, Lindzey J, Kimbro KS, Eddy EM, Migliaccio S, Snedeker SM, Lubahn DB, Schomberg DW, Smith EP 1996 Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. Recent Prog Horm Res 51:159-186
9. Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF, Sar M, Korach KS, Gustafsson JA, Smithies O 1998 Generation and reproductive phenotypes of mice lacking estrogen receptor β. Proc Natl Acad Sci USA 95:15677-15682
10. Couse JF, Curtis HS, Korach KS 2000 Receptor null mice reveal contrasting roles for estrogen receptor α and β in reproductive tissues. J Steroid Biochem Mol Biol 74: 287-296
11. Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P, Mark M 2000 Effect of single and compound knockouts of estrogen receptors α (ERα) and β (ERβ) on mouse reproductive phenotypes. Development 127:4277-4291
12. Weihua Z, Makela S, Andersson LC, Salmi S, Saji S, Webster JI, Jensen EV, Nilsson S, Warner M, Gustafsson JA 2001 A role for estrogen receptor β in the regulation of growth of the ventral prostate. Proc Natl Acad Sci USA 98:6330-6335
13. Harris HA, Katzenellenbogen JA, Katzenellenbogen BS 2002 Characterization of the biological roles of the estrogen receptors, ERα and ERβ, in estrogen target tissues in vivo through the use of an ERα-selective ligand. Endocrinology 143:4172-4177
14. Harrington WR, Sheng S, Barnett DH, Petz LN, Katzenellenbogen JA, Katzenellenbogen BS 2003 Activities of estrogen receptor α- and β-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Mol Cell Endocrinol 206:13-22
15. Harris HA, Albert LM, Leathurby Y, Malamas MS, Mewshaw RE, Miller CP, Kharode YP, Marzolf J, Komm BS, Winneker RC, Frail DE, Henderson RA, Zhu Y, Keith Jr JC 2003 Evaluation of an estrogen receptor-β agonist in animal models of human disease. Endocrinology 144: 4241-4249
16. Stauffer SR, Coletta CJ, Tedesco R, Nishiguchi G, Carlson K, Sun J, Katzenellenbogen BS, Katzenellenbogen JA 2000 Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-α- selective agonists. J Med Chem 43:4934-4947
17. Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA 2001 Estrogen receptor-β potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem 44:4230-4251
18. Tanenbaum DM, Wang Y, Williams SP, Sigler PB 1998 Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. Proc Natl Acad Sci USA 95:5998-6003
19. Peters O, Hillisch A, Thieme I, Elger W, Hegele-Hartung C, Kollenkirchen U, Fritzemeier K-H, Patchev V. 8β-Hydrocarbyl-substituted estratrienes for use as selective estrogens. WO0177139. 12-4-2000 (patent application)
20. Fritzemeier K-H, Kollenkirchen U, Kosemund D, Müller G. 19-Nor-17 α-pregna-1,3,5 (10)-trien-17β-ols of a 21,16α-lactone ring. WO0226763. 4-10-2000 (patent application)
21. Lindberg MK, Moverare S, Skrtic S, Gao H, Dahlman-Wright K, Gustafsson JA, Ohlsson C 2003 Estrogen receptor (ER)-β reduces ERα-regulated gene transcription, supporting a "Ying Yang" relationship between ERα and ERβ in mice. Mol Endocrinol 17:203-208
22. Pike AC, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, Engstrom O, Ljunggren J, Gustafsson JA, Carlquist M 1999 Structure of the ligand-binding domain of oestrogen receptor β in the presence of a partial agonist and a full antagonist. EMBO J 18:4608-4618
23. Williams SP, Sigler PB 1998 Atomic structure of progesterone complexed with its receptor. Nature 393:392-396
24. Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson JA, Carlquist M 1997 Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389:753-758
25. Öhman L, Bonn T, Carlquist M, Engström O, Goede P, Hedfors A, Holmgren E, Koehler K, Brzozowski AM, Pike AC, Hubbard RE. Estrogen receptor ligands. PCT/GB98/ 01708[WO 98/56812]. 17-12-1998 (patent application)
26. Sun J, Baudry J, Katzenellenbogen JA, Katzenellenbogen BS 2003 Molecular basis for the subtype discrimination of the estrogen receptor-β-selective ligand, diarylpropionitrile. Mol Endocrinol 17:247-258
27. Nettles KW, Sun J, Radek JT, Sheng S, Rodriguez AL, Katzenellenbogen JA, Katzenellenbogen BS, Greene GL 2004 Allosteric control of ligand selectivity between estrogen receptors α and β: implications for other nuclear receptors. Mol Cell 13:317-327
28. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA 1997 Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138:863-870
29. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der BB, Gustafsson JA 1998 Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139:4252-4263
30. Bajpai M, Doncel GF 2003 Involvement of tyrosine kinase and cAMP-dependent kinase cross-talk in the regulation of human sperm motility. Reproduction 126:183-195
31. Evans BA, Griffiths K, Morton MS 1995 Inhibition of 5 α-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol 147:295-302
32. Krattenmacher R, Knauthe R, Parczyk K, Walker A, Hilgenfeldt U, Fritzemeier KH 1994 Estrogen action on hepatic synthesis of angiotensinogen and IGF-I: direct and indirect estrogen effects. J Steroid Biochem Mol Biol 48:207-214
33. Lim SK, Won YJ, Lee HC, Huh KB, Park YS 1999 A PCR analysis of ERα and ERβ mRNA abundance in rats and the effect of ovariectomy. J Bone Miner Res 14:1189-1196
34. Freeman ME 1994 The neuroendocrine control of the ovarian cycle of the rat. In: Knobil E, Neill JD, eds. The physiology of reproduction. New York: Raven Press; 613-658
35. Hegele-Hartung C, Siebel P, Peters O, Kosemund D, Muller G, Hillisch A, Walter A, Kraetzschmar J, Fritzemeier KH 2004 Impact of isotype-selective estrogen receptor agonists on ovarian function. Proc Natl Acad Sci USA 101:5129-5134
36. Thompson JD, Higgins DG, Gibson TJ 1994 CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673-4680
37. Hillisch A, Hilgenfeld R 2003 The role of protein 3D-structures in the drug discovery process. In: Hillisch A, Hilgenfeld R, eds. Modern methods of drug discovery. Boston: Birkhäuser Verlag AG; 157-181
38. Halgren T 1996 Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J Comp Chem 17:490-519
39. Fritzemeier KH, Hegele-Hartung C 1999 In vitro and in vivo models to characterize estrogens and antiestrogens. In: Oettel M, Schillinger E, eds. Handbook of experimental pharmacology, vol 135/II. Estrogens and antiestrogens II. Berlin: Springer Verlag
40. Fuhrmann U, Slater EP, Fritzemeier KH 1995 Characterization of the novel progestin gestodene by receptor binding studies and transactivation assays. Contraception 51:45-52
41. Jung-Testas I, Groyer MT, Bruner-Lorand J, Hechter O, Baulieu EE, Robel P 1981 Androgen and estrogen receptors in rat ventral prostate epithelium and stroma. Endocrinology 109:1287-1289
42. Stack G, Gorski J 1985 Relationship of estrogen receptors and protein synthesis to the mitogenic effect of estrogens. Endocrinology 117:2024-2032